In December 2021, the Czech Science Foundation has selected research projects to be funded starting in January 2022. In the competition of hundreds of projects from all over the Czech Republic, a total of 5 projects from the Faculty of Pharmacy in Hradec Králové (FaF UK) were funded, which will bring a total of 35 416 000 CZK (1.5 mil. EUR) to Faculty in the next three years.
The project of Mgr. Ing. Tomáš Hodík, Dr. rer. nat., titled Chalcogen Bonding Catalysis - New Perspective in Organocatalysis, was selected for funding in the POSTDOC INDIVIDUAL FELLOWSHIP INCOMING call. This was the only project submitted by the faculty.
The other four projects from FaF UK were selected to be funded in the STANDARD PROJECTS call:
Impact of direct endoglin modulation on the development of major complications of metabolic syndrome: atherogenesis and non-alcoholic steatohepatitis; principal investigator: prof. PharmDr. Petr Nachtigal, Ph.D.
Perspective application of xenosensor nuclear receptors ligands in therapy of cholestatic liver diseases; principal investigator: prof. PharmDr. Petr Pávek, Ph.D. (co-beneficiary: Institute of Molecular Genetics of the Czech Academy of Sciences).
Heterodendralene-based approach to isocoumarins and isolycoricidine; principal investigator:
prof. RNDr. Milan Pour, Ph.D.
Impact of maternal immune activation on serotonergic system in the fetoplacental unit and fetal, juvenile and adult neurodevelopment; principal investigator prof. PharmDr. František Štaud, Ph.D.; (co-beneficiary: Institute of Physiology of the Czech Academy of Sciences).
Czech Science Foundation has funded fewer than 20 % of the project proposals. Thus, out of a total of 18 submitted projects from FaF UK, we reached an above-average 22% success rate!
Congratulations to all principal investigators. We wish them high-quality results and success in their projects!
Text: Ing. Martina Doležalová, Assoc. Prof. Jaroslav Roh